Figure 5. mCuMVTT-RBM induces higher antibody
titers in comparison to SARS-CoV-2 convalescent sera
A, RBD-specific IgG titer for mice sera on D14 after priming with
mCuMVTT-RBM and COVID-19 convalescent sera (total 5
sera) measured with OD450. B, RBD-specific IgG titer for
mice sera on D28 after priming with mCuMVTT-RBM and
COVID-19 convalescent sera (total 5 sera) measured with
OD450. C, Area under curve (AUC) for RBD-specific IgG
titer for mice sera on D14 after priming with
mCuMVTT-RBM and COVID-19 convalescent sera (total 5
sera). D, Area under curve (AUC) for RBD-specific IgG titer for mice
sera on D28 after priming with mCuMVTT-RBM and COVID-19
convalescent sera (total 5 sera). Statistical analysis (mean ± SEM)
using Student’s t-test , n=5 . One representative of 2
similar experiments is shown. The value of p <0.05 was
considered statistically significant (*p <0.01,
**p <0.001, ***p <0.0001).